Lowgrade Serous Ovarian Cancer | Latest News RSS Feed

Lowgrade Serous Ovarian Cancer - Latest News


Dunedin woman secures free Times Square billboard to mark World Ovarian Cancer Day

The giant advertisement is longer than a football field. read more

Add your link right here

Add your story here to improve SEO, search ranking and drive traffic to your website. Your link will be permanently featured right on this page. To add a link on diferent page, just visit the page you want to show your link and click "Add your link right here". You can use search form below to find the page. read more

A Phase III Study of Letrozole Alone or with Chemotherapy in Women with Low-Grade Serous Ovarian or Peritoneal Cancer

To be eligible for this study, patients must meet several criteria, including but not limited to the following: Patients must have newly diagnosed stage II-IV low-grade serous ovarian or peritoneal ... read more

Treatment for rare ovarian cancer ‘could quadruple chance of response’

Women with a rare type of ovarian cancer could benefit from a drug that quadruples the likelihood of response, according to scientists. Low grade serous ovarian cancer affects women at a younger ... read more

Looking for another news?


One Strikeout, One Hit Against Low-Grade

752). "Although this study did not meet its primary endpoint, binimetinib showed activity in low-grade serous ovarian cancer across the efficacy endpoints evaluated, with a response rate of 24% ... read more


The untapped potential of ascites in ovarian cancer research and treatment

Fig. 2: Mechanism of ascites build-up in ovarian cancer. Fig. 3: Three different sized spheroids isolated from a patient with low-grade serous ovarian cancer (LGSOC). read more

KRAS May Predict Benefit of MEK Inhibitors in Some Ovarian Cancers

For women with recurrent or persistent low-grade serous ovarian cancer (LGSOC), presence of a KRAS mutation appeared to predict benefit from binimetinib (Mektovi), a post-hoc analysis from the ... read more

Lung cancer data fails to lift Verastem, down 17% premarket

In low-grade serous ovarian cancer cohort, 4 out of 6 patients responded, for an overall response rate (ORR) of 67%. Median time on treatment was 20.5 months. In non-small cell lung cancer (NSCLC ... read more

Integrative genomics approach identifies molecular features associated with early-stage ovarian carcinoma histotypes

Ovarian cancer comprises multiple subtypes (clear-cell (CCC), endometrioid (EC), high-grade serous (HGSC), low-grade serous (LGSC), and mucinous carcinomas (MC)) with differing molecular and ... read more

Ovarian Cancer News

J&J Baby Powder Withdrawn in US After Years of Cancer Litigation ... BRCA-positive ovarian cancer. Medscape Medical News, May 14, 2020 One Strikeout, One Hit Against Low-Grade Serous Carcinomas ... read more

2017 Ovarian Cancer National Conference

ovarian low-grade serous carcinoma, and mucinous tumors. For women with ovarian cancer, the message is clear: participating in clinical trials, even early-phase ones, offers the best hope for better ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us